Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Evaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Italy Poland Spain
  • A study of SKB410, enfortumab vedotin, and pembrolizumab combination for patients with locally advanced or metastatic urothelial cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands Spain
  • Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

    Recruiting

    4 1 1
    Investigated Drugs:
    Poland Slovakia
  • A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Czechia Denmark France Germany Greece +3
  • A Study of Prednisolone, Mycophenolate Mofetil and Voclosporin Compared to Prednisolone and Mycophenolate Mofetil in Patients with Lupus Nephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • A Study of IPN01203 for Adults With Advanced or Metastatic Solid Tumors After Immune Checkpoint Inhibitor Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    France Spain
  • Study comparing treatment with or without tislelizumab for patients with locally advanced rectal cancer to see if surgery can be avoided

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany
  • A Study of IPN60300 in Adults with Locally Advanced or Metastatic Solid Tumors to Assess Safety, Tolerability and Anti-Cancer Activity

    Recruiting

    2 1 1
    Investigated Diseases:
    France Spain
  • A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

    Recruiting

    2 1
    Belgium Denmark France Germany Italy The Netherlands +1